ELF patient organisation programme

A look at how physicians and patients manage to work and communicate together to produce a successful Clinical Research Collaboration.

Lung cancer or cancer of the lung

A discussion about different care pathways for people with lung cancer, who should manage their care, and whether pulmonologists can keep up to date with new tests and treatments.

A look at how to manage the care of patients with stable but severe COPD, including the different risk factors and types of treatment, and managing other health conditions.

The latest scientific discoveries on lung health, including how events before birth and during childhood can affect lung health, how factors such as diet and genes can influence the severity of childhood asthma, how factors such as lifestyle and environment affect the development of COPD and the similarities between lung cancer and idiopathic pulmonary fibrosis.

Physiotherapy in chronic respiratory infections

A look at whether respiratory physiotherapy can prevent exacerbations (flare-ups) and reduce the effect of chronic infections in patients with lung diseases, including COPD, bronchiectasis, asthma and cystic fibrosis.

A look at how the use of nicotine and cannabis products has changed; how new cannabis, tobacco and nicotine products might affect health, and why we should involve respiratory health care providers, researchers, patients and the public in the cannabis legalisation debate.

This session explains how and why patients should represent themselves and others in areas such as research, guideline production, advocacy and conferences such as the ERS Congress.

Why patients experience antibiotic resistance and how patients’ own immunity could be used to improve the effectiveness of antibiotics.

10:40-11:40

A look at how pulmonary fibrosis can develop in sarcoidosis, the risk factors for severe pulmonary sarcoidosis, how to identify the patients with severe pulmonary sarcoidosis who are the most unwell and how to manage cardiac sarcoidosis.

The different ways of improving breathing and lung health, including ways of measuring how well the lungs are working.

The latest scientific developments in cystic fibrosis (CF). Includes managing lung infections; pancreatic and liver disease in people with CF; difficulties in making sure patients follow their treatment; social and emotional well-being, and new treatments.

A look at the nerves in the airway and how new treatments for chronic cough target these nerves, plus an explanation of  cough reflex hypersensitivity.

An overview of research into sleep and breathing disorders from the past 30 years and a look at new topics and developments.

Exploring the relationship between smoking, nicotine and COVID-19, including whether smoking worsens the disease, whether exhaled cigarette smoke can transmit COVID, and recent findings from research and how they may affect public health.

The effect that exercise has on sleep disorders, and managing these disorders using exercise.

A look at asthma management, including treatment for mild asthma; biological therapies for severe asthma; why some patients don’t respond to treatment, and severe neutrophilic asthma.

Exciting new developments in lung cancer screening, diagnostics and treatment

New scientific developments, including how different microorganisms affect lung cancer, immunotherapy for small cell lung cancer, and non-invasive treatment of breathlessness and pain.

9:30-10:30

How to lessen the impact of asthma on daily life, including identifying what could worsen or reduce asthma; treatments that target asthma genes, and managing severe asthma in children.

10:40-11.40

A look at the biology of cystic fibrosis (CF) and caring for patients with the disease. Includes lung inflammation; moving from adolescent to adult care; gastrointestinal problems; other illnesses that patients with CF may have, and changes in who gets CF and how they are cared for.

10:40-11.40

How doctors can choose the best way to diagnose and treat patients with common respiratory symptoms, such as breathlessness, and how doctors can support events such as No Smoking Week.

More ways in which doctors can choose the best way to diagnose and treat patients with common respiratory symptoms, including an overview of the frequency and causes of lung diseases, other illnesses that lung patients might have, drug treatments for patients who have COPD together with other illnesses, the circulation and the lung and managing lung diseases in pregnant women.

How the work environment can affect lung health, including how work-related lung diseases can be better recognised and treated, and how to look after these patients in the workplace.

Is there a problem with...? Treatment approaches in asthma and COPD

A look at concerns about the use of short-acting beta-2 agonist (SABA) monotherapy and oral corticosteroid (OCS) in asthma and inhaled corticosteroids (ICS) in COPD, and the best inhalation device for patients with COPD.

A look at new treatments for patients with pulmonary hypertension, interstitial lung diseases and cystic fibrosis and how this can affect lung transplants.

How fear and anxiety can affect asthma and COPD, and a look at new care and treatments that could help, including behavioural treatment and e-health.

A look at asthma management, including treatment for mild asthma; biological therapies for severe asthma; why some patients don’t respond to treatment, and severe neutrophilic asthma.

Recent scientific discoveries in genes and pulmonary hypertension, and how other lung developmental disorders might lead to pulmonary hypertension.

A description of the different types of asthma and how they are diagnosed and treated. Includes a patient perspective.

A summary of what we know about the microbiome – the bacteria and other organisms that live in the body - and its effect on lung health.

Clinical Grand Round: revisiting current guidelines

A look at controversial aspects of the current guidelines in cough, community-acquired pneumonia, surgery for lung cancer and pulmonary embolism.

18:00-19:00

A look at interstitial lung disease (ILD), including how idiopathic pulmonary fibrosis develops and is treated and diagnosed, how diseases such as scleroderma, sarcoidosis and rheumatoid arthritis can lead to pulmonary fibrosis and treatment of ILDs that get worse very quickly.

Insights from wearable respiratory sensors and AI

How wearable sensors can improve treatment and care for conditions such as COPD and sleep apnoea, and how artificial intelligence helped provide data about the COVID pandemic.

9:30-10:30

The latest scientific developments on how to manage lung cancer and other tumours of the thorax.

11:50-12:50

How digital technology, such as sensors, monitors, and artificial intelligence, can improve the treatment and care of lung diseases. Includes a patient perspective.

11:50-12:50

The latest scientific developments in diagnosis and treatment of ILD, including hypersensitivity pneumonitis and the role of genetics in ILDs.

An overview of different methods to help patients stop smoking and how these methods can work with other health systems. Includes a patient perspective.

A look how early life can affect the development of bronchiectasis, and new and future treatments for the disease.

18:00-19:00

Managing frailty in patients with acute or chronic lung disorders

A definition of frailty and its connection with lung disease, and how rehabilitation therapy can help.